FTC Launches Inquiry into Gender-Affirming Care for Minors Amidst Growing Concerns
Dr. Kurt Miceli, medical director of advocacy group Do No Harm, has welcomed the Federal Trade Commission's (FTC) public inquiry into gender-affirming care for minors. The investigation aims to understand how such treatments may have harmed or deceived consumers. Miceli believes that over half of US states are already taking action to protect children from these potential harms.
The FTC launched this inquiry following a workshop held last year, which explored the dangers and deceptive practices surrounding gender-affirming care for minors. Miceli anticipates that the FTC will take action based on the public comments received during this process. Do No Harm, an organisation dedicated to protecting children and defending science, disputes claims that such care is safe, effective, and reduces suicide risk in minors.
Miceli suggests a multifaceted strategy involving government agencies and Congress to end transgender procedures on minors. He calls for more physicians to speak out against harmful practices and for medical associations to follow evidence-based guidelines. Do No Harm expects the FTC to take action protecting children from harmful transgender interventions and seeking justice for those already affected.
Dr. Kurt Miceli's advocacy, along with Do No Harm's efforts, has brought increased scrutiny to gender-affirming care for minors. The FTC's public inquiry signals a significant step towards understanding and addressing potential harms. Miceli's call for evidence-based practices and government intervention highlights the complex nature of this debate and its potential impact on the lives of many children.
